NLS Clinical Trials Medtech

Random Walk Imaging (RWI) has announced positive data from a study in multiple sclerosis (MS) patients using the company’s scanning method and software protocol. Data from the study, which was conducted at the Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre, demonstrated a significant improvement in the sensitivity of MRI images to disease […]

The company is partnering with Beijing University Cancer Hospital and Konica Minolta in a clinical trial to assess the efficacy of scalp cooling for chemotherapy-induced hair loss in women with breast cancer. Dr. Tao Ouyang, Chairman of Breast Center of Beijing University Cancer Hospital will lead the study which includes 256 patients at Beijing University Cancer Hospital over […]

The company has announced new data from the CERTiFy (CERAMENT Treatment of Tibia Plateau Fracture defects) study comparing CERAMENT|BVF with autologous iliac bone graft (autograft). “Successfully completing the ground-breaking CERTiFy study, to demonstrate CERAMENT BVF is non-inferior to autograft in treating tibia plateau fracture defects, is a major milestone for BONESUPPORT. We expect the results from the study […]

OssDsign AB has announced positive results from a retrospective study of OSSDSIGN Cranial PSI that has been accepted for publication in World Neurosurgery. The retrospective study carried out at Karolinska University Hospital in Sweden describes the clinical outcome of 50 patients who underwent cranioplasty with a total of 53 OSSDSIGN Cranial implants. 64% of the patients […]

Acarix announces that two Swedish hospitals – Kristianstad and Sunderbyn – have evaluated the CADScor System for rule-out of Coronary Artery Disease. The evaluation compares favorably against existing methods and offers the possibility of avoiding expensive invasive methods, reports the company. Kristianstad will now integrate the CADScor System in daily clinical practice while Sunderbyn will […]

The company has been chosen as sole supplier to a screening project for atrial fibrillation in Great Britain. The project is the largest longterm screening project with the aim to prevent stroke in the world to date, and the largest single deal in the 15 year history of Zenicor, according to the company press release. […]